Search research articles
Contact Us
Filters
Showing results (51-60 of 182) with videos related to
Page
of 19
Sort By:
Annals of Surgical Oncology
|
May 24, 2012
The New American Joint Committee on Cancer/International Union Against Cancer staging system for adenocarcinoma of the stomach: increased complexity without clear improvement in predictive accuracy
Johan L Dikken, Cornelis J H van de Velde, Mithat Gönen, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
November 7, 2012
Can adjuvant chemoradiotherapy replace extended lymph node dissection in gastric cancer?
Edwin P M Jansen, Henk Boot, Cornelis J H van de Velde, et al.
Therapeutic Advances in Gastroenterology
|
January 28, 2012
Treatment of resectable gastric cancer
Johan L Dikken, Cornelis J H van de Velde, Daniel G Coit, et al.
Frontiers in Immunology
|
May 3, 2021
Immune Modulation Plus Tumor Ablation: Adjuvants and Antibodies to Prime and Boost Anti-Tumor Immunity <i>In Situ</i>
Renske J E van den Bijgaart, Fabian Schuurmans, Jurgen J Fütterer, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
August 13, 2011
Extended lymph node dissection for gastric cancer from a European perspective
Johan L Dikken, Marcel Verheij, Annemieke Cats, et al.
Nuclear Medicine Communications
|
December 1, 2007
99mTc-HYNIC-rh-annexin-V scintigraphy: visual and quantitative evaluation of early treatment-induced apoptosis to predict treatment outcome
Marina S Kartachova, Renato A Valdés Olmos, Rick L M Haas, et al.
The Biochemical Journal
|
October 15, 2009
Fas/CD95 down-regulation in lymphoma cells through acquired alkyllysophospholipid resistance: partial role of associated sphingomyelin deficiency
Wim J van Blitterswijk, Jeffrey B Klarenbeek, Arnold H van der Luit, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 19, 2006
TRAIL enhances efficacy of radiotherapy in a p53 mutant, Bcl-2 overexpressing lymphoid malignancy
Esther H J Wissink, Inge Verbrugge, Stefan R Vink, et al.
The Biochemical Journal
|
October 20, 2006
Resistance to alkyl-lysophospholipid-induced apoptosis due to downregulated sphingomyelin synthase 1 expression with consequent sphingomyelin- and cholesterol-deficiency in lipid rafts
Arnold H Van der Luit, Marianne Budde, Shuraila Zerp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 15, 2006
Radiosensitization of squamous cell carcinoma by the alkylphospholipid perifosine in cell culture and xenografts
Stefan R Vink, Saskia Lagerwerf, Elly Mesman, et al.
Page
of 19
Search research articles
Search
Showing results (51-60 of 182) with videos related to
Sort By:
Page
of 19
Annals of Surgical Oncology
|
May 24, 2012
The New American Joint Committee on Cancer/International Union Against Cancer staging system for adenocarcinoma of the stomach: increased complexity without clear improvement in predictive accuracy
Johan L Dikken, Cornelis J H van de Velde, Mithat Gönen, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
November 7, 2012
Can adjuvant chemoradiotherapy replace extended lymph node dissection in gastric cancer?
Edwin P M Jansen, Henk Boot, Cornelis J H van de Velde, et al.
Therapeutic Advances in Gastroenterology
|
January 28, 2012
Treatment of resectable gastric cancer
Johan L Dikken, Cornelis J H van de Velde, Daniel G Coit, et al.
Frontiers in Immunology
|
May 3, 2021
Immune Modulation Plus Tumor Ablation: Adjuvants and Antibodies to Prime and Boost Anti-Tumor Immunity <i>In Situ</i>
Renske J E van den Bijgaart, Fabian Schuurmans, Jurgen J Fütterer, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
August 13, 2011
Extended lymph node dissection for gastric cancer from a European perspective
Johan L Dikken, Marcel Verheij, Annemieke Cats, et al.
Nuclear Medicine Communications
|
December 1, 2007
99mTc-HYNIC-rh-annexin-V scintigraphy: visual and quantitative evaluation of early treatment-induced apoptosis to predict treatment outcome
Marina S Kartachova, Renato A Valdés Olmos, Rick L M Haas, et al.
The Biochemical Journal
|
October 15, 2009
Fas/CD95 down-regulation in lymphoma cells through acquired alkyllysophospholipid resistance: partial role of associated sphingomyelin deficiency
Wim J van Blitterswijk, Jeffrey B Klarenbeek, Arnold H van der Luit, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 19, 2006
TRAIL enhances efficacy of radiotherapy in a p53 mutant, Bcl-2 overexpressing lymphoid malignancy
Esther H J Wissink, Inge Verbrugge, Stefan R Vink, et al.
The Biochemical Journal
|
October 20, 2006
Resistance to alkyl-lysophospholipid-induced apoptosis due to downregulated sphingomyelin synthase 1 expression with consequent sphingomyelin- and cholesterol-deficiency in lipid rafts
Arnold H Van der Luit, Marianne Budde, Shuraila Zerp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 15, 2006
Radiosensitization of squamous cell carcinoma by the alkylphospholipid perifosine in cell culture and xenografts
Stefan R Vink, Saskia Lagerwerf, Elly Mesman, et al.
Page
of 19